First patient enrolled in SOZO CHF Trial at Scripps Health
Filed with ASX · · 2 pages · English
Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings CallStory so far
Earlier from ImpediMed
- Appendix 4C - Quarter ended 30 June 2017
- IPD Submits FDA 510(k) Application for SOZO for Lymphoedema
- L-Dex Recommended in Clinical Practice Guidelines
- SOZO obtains CE Mark for Heart Failure Patient Monitoring
- Macquarie University Commences Lymphoedema Study Using Sozo
Later from ImpediMed
- US FDA 510(k) Clearance Issued for SOZO with L-Dex
- Heart Failure 510(k) Application for SOZO Submitted to FDA
- Appendix 4E - year ended 30 June 2017
- New Study Reports Superior Clinical Outcomes Utilising L-Dex
- Shipments of SOZO with L-Dex Commence in the US
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed